tiprankstipranks
Coherus Biosciences (CH:8C5)
NASDAQ:8C5
Switzerland Market
8C5
Coherus Biosciences
RESEARCH TOOLSreports

Coherus Biosciences (8C5) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

8C5 Analyst Ratings

Strong Buy
5Ratings
Strong Buy
5 Buy
0 Hold
0 Sell
Based on 5 analysts giving stock ratings to
Coherus
Biosciences
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

8C5 Stock 12 Month Forecast

Average Price Target

$6.64
Based on 5 Wall Street analysts offering 12 month price targets for Coherus Biosciences in the last 3 months. The average price target is $6.64 with a high forecast of $9.66 and a low forecast of $3.22. The average price target represents a ― change from the last price of ―.
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
Highest Price Target$9.66Average Price Target$6.64Lowest Price Target$3.22
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Oppenheimer Analyst forecast on CH:8C5
Jay Olson
Oppenheimer
Oppenheimer
CHF8.05
Buy
―
Reiterated
06/22/26
Analysts Are Bullish on These Healthcare Stocks: Boston Scientific (BSX), Coherus Biosciences (CHRS)
TD Cowen Analyst forecast on CH:8C5
Michael Nedelcovych
TD Cowen
TD Cowen
―
Buy
―
Reiterated
05/28/26
Analysts' Top Healthcare Picks: Coherus Biosciences (CHRS), Medicinova (MNOV)
H.C. Wainwright Analyst forecast on CH:8C5
Douglas Tsao
H.C. Wainwright
H.C. Wainwright
CHF5.64
Buy
―
Reiterated
05/12/26
Analyst Reiterates Buy on Loqtorzi Momentum and Temporary Q1 Headwinds; $7 Price Target Maintained
Maxim Group Analyst forecast on CH:8C5
Jason McCarthy
Maxim Group
Maxim Group
CHF3.22
Buy
―
Reiterated
05/12/26
Analysts Are Bullish on These Healthcare Stocks: Immunome (IMNM), Coherus Biosciences (CHRS)
Guggenheim Analyst forecast on CH:8C5
Paul Jeng
Guggenheim
Guggenheim
CHF9.66
Buy
―
Initiated
05/11/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Coherus Biosciences (NASDAQ: CHRS), Moderna (NASDAQ: MRNA) and Skye Bioscience (NASDAQ: SKYE)
UBS Analyst forecast on CH:8C5
Ashwani Verma
UBS
UBS
CHF0.85→CHF0.89
Hold
―
Reiterated
07/21/25
UBS Sticks to Their Hold Rating for Coherus Biosciences (CHRS)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Oppenheimer Analyst forecast on CH:8C5
Jay Olson
Oppenheimer
Oppenheimer
CHF8.05
Buy
―
Reiterated
06/22/26
Analysts Are Bullish on These Healthcare Stocks: Boston Scientific (BSX), Coherus Biosciences (CHRS)
TD Cowen Analyst forecast on CH:8C5
Michael Nedelcovych
TD Cowen
TD Cowen
―
Buy
―
Reiterated
05/28/26
Analysts' Top Healthcare Picks: Coherus Biosciences (CHRS), Medicinova (MNOV)
H.C. Wainwright Analyst forecast on CH:8C5
Douglas Tsao
H.C. Wainwright
H.C. Wainwright
CHF5.64
Buy
―
Reiterated
05/12/26
Analyst Reiterates Buy on Loqtorzi Momentum and Temporary Q1 Headwinds; $7 Price Target Maintained
Maxim Group Analyst forecast on CH:8C5
Jason McCarthy
Maxim Group
Maxim Group
CHF3.22
Buy
―
Reiterated
05/12/26
Analysts Are Bullish on These Healthcare Stocks: Immunome (IMNM), Coherus Biosciences (CHRS)
Guggenheim Analyst forecast on CH:8C5
Paul Jeng
Guggenheim
Guggenheim
CHF9.66
Buy
―
Initiated
05/11/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Coherus Biosciences (NASDAQ: CHRS), Moderna (NASDAQ: MRNA) and Skye Bioscience (NASDAQ: SKYE)
UBS Analyst forecast on CH:8C5
Ashwani Verma
UBS
UBS
CHF0.85→CHF0.89
Hold
―
Reiterated
07/21/25
UBS Sticks to Their Hold Rating for Coherus Biosciences (CHRS)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BBOTBridgeBio Oncology Therapeutics
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Coherus Biosciences

3 Months
Michael NedelcovychTD Cowen
Success Rate
5/13 ratings generated profit
38%
Average Return
+3.14%
Copying Michael Nedelcovych's trades and holding each position for 3 Months would result in 38.46% of your transactions generating a profit, with an average return of +3.14% per trade.
1 Year
Michael NedelcovychTD Cowen
Success Rate
6/13 ratings generated profit
46%
Average Return
+9.75%
Copying Michael Nedelcovych's trades and holding each position for 1 Year would result in 46.15% of your transactions generating a profit, with an average return of +9.75% per trade.
2 Years
Michael NedelcovychTD Cowen
Success Rate
7/13 ratings generated profit
54%
Average Return
+21.34%
Copying Michael Nedelcovych's trades and holding each position for 2 Years would result in 53.85% of your transactions generating a profit, with an average return of +21.34% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

8C5 Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
4
5
8
7
5
Buy
1
1
2
1
1
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
6
10
8
6
In the current month, 8C5 has received 6 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 8C5 average Analyst price target in the past 3 months is 6.64.
Each month's total comprises the sum of three months' worth of ratings.

8C5 Financial Forecast

8C5 Earnings Forecast

Next quarter’s earnings estimate for 8C5 is -$0.20 with a range of -$0.23 to -$0.14. The previous quarter’s EPS was -$0.22. 8C5 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year 8C5 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 8C5 is -$0.20 with a range of -$0.23 to -$0.14. The previous quarter’s EPS was -$0.22. 8C5 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year 8C5 has Performed in-line its overall industry.

8C5 Sales Forecast

Next quarter’s sales forecast for 8C5 is $11.59M with a range of $10.70M to $12.46M. The previous quarter’s sales results were $9.90M. 8C5 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year 8C5 has Performed in-line its overall industry.
Next quarter’s sales forecast for 8C5 is $11.59M with a range of $10.70M to $12.46M. The previous quarter’s sales results were $9.90M. 8C5 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year 8C5 has Performed in-line its overall industry.

8C5 Stock Forecast FAQ

What is CH:8C5’s average 12-month price target, according to analysts?
Based on analyst ratings, Coherus Biosciences’s 12-month average price target is 6.64.
    What is CH:8C5’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:8C5, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Coherus Biosciences a Buy, Sell or Hold?
        Coherus Biosciences has a consensus rating of Strong Buy, which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
          What is Coherus Biosciences’s share price target?
          The average share price target for Coherus Biosciences is 6.64. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $9.66 ,and the lowest forecast is $3.22. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Coherus Biosciences?
            Coherus Biosciences’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
              How can I buy shares of Coherus Biosciences?
              To buy shares of CH:8C5, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.